DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20184130

Effect of antibiotics on inflammatory marker (IL-6) and perinatal outcomes in women with preterm premature rupture of membranes

Ashima Arora, Ratna Biswas, Bhawna Dubey, Binita Goswami, Sonal Saxena

Abstract


Background: The aim is to study the effect of antibiotics on inflammatory marker (IL-6) and perinatal outcomes in women with preterm premature rupture of membranes (PPROM).

Methods: 60 women with PPROM at 28–34 weeks of gestation were enrolled in the study. All the women were given antibiotics as per hospital protocol and were subjected to blood sampling for Interleukin -6(IL-6) at admission, delivery and umbilical cord blood. IL-6 levels were assessed for associations with adverse perinatal outcomes and the effect of antibiotic treatment on IL-6 and perinatal outcomes were studied. The data were analyzed using t test and χ2 test.

Results: Increased level of IL-6 was associated with chorioamnionitis and neonatal sepsis (p<0.001). High level of IL-6 led to early delivery and complete course of antibiotics suppressed IL-6 (p<0.001) and clinical chorioamnionitis in women with PROM. Full course of antibiotics also decreased the admission rate of babies to neonatal intensive care unit and suppressed respiratory distress syndrome, neonatal sepsis.

Conclusions: Increased level of IL-6 is seen in women with chorioamnionitis and neonatal sepsis. Antibiotics suppress the IL-6 levels, chorioamnionitis and neonatal sepsis.


Keywords


Antibiotics, Chorioamnionitis, IL-6, Neonatal sepsis, Premature rupture of membranes, PROM

Full Text:

PDF

References


ACOG Committee on Practice Bulletins-Obstetrics. Premature Rupture of Membranes. (ACOG Practice Bulletin No. 1). Obstetric Gynecol. 1998;143:625-6.

ACOG Committee on Practice Bulletins-Obstetrics. Clinical management guidelines for obstetrician-gynecologists. (ACOG Practice Bulletin No. 80: premature rupture of membranes). Obstetric Gynecol. 2007;109:1007-19.

Bhalero S, Desai A. Premature rupture of membranes. In: Saraiya UB, Rao KB, Chatterjee A, editors. Principles and Practice of Obstetrics and Gynaecology. 2nd ed. New Delhi: Jaypee Brothers; 2003:125.

Bhide AG. Pregnancy at risk: current concepts. In: Krishna UR, Tank DK, Daftary SN, editors. Premature Rupture of Membranes. 4th ed. New Delhi: Jaypee Brothers; 2001:203.

Parry S, Strauss JF. Premature rupture of the fetal membranes: review. N Eng J Med. 1998;338(10):663-70.

Yoon B, Romero R, Park JS, Kim M, Oh SY, Kin CJ et al. The relationship among inflammatory lesions of the umbilical cord (funisitis), Umblical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol. 2000;183(5):1124-9.

Athayde N, Edwin SS, Romero R, Gomez R, Maymon E, Pacora Pet al. A role of matrix metalloproteinase-9 in spontaneous rupture of fetal membranes. Am J Obstet Gynecol. 1998;179(5):1248-53.

Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel L, Hassan S. The role of inflammation and infection in Preterm Birth. Semin Reprod Med. 2007;25(1):21-39.

Dale PO, Tanbo T, Bendvold E, Moe N. Duration of the latency period in preterm premature rupture of the membranes. Maternal and neonatal consequences of expectant management. Eur J Obstet Gynecol Reprod Biol. 1989;30(3):257-62.

Bengtson JM, Vanmarter LJ, Barss VA, Greene MF, Tuomala RE, Epstein MF. Pregnancy outcome after premature rupture of membranes at or before 26 weeks’ gestation. Obstet Gynecol. 1989;73(6):921-7.

ACOG Committee on Practice Bulletins-Obstetrics. Clinical management guidelines for obstetrician-gynecologists. (ACOG Practice Bulletin No. 139: premature rupture of membranes). Obstetric Gynecol. 2013;122:918-30.

Royal College of Obstetricians and Gynaecologists. Preterm labour rupture of membranes. Royal college of Obstetricians and gynaecologists. 2006. Guideline No. 44.

Centers for Disease Control and prevention (CDC) Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC. Morbidity and mortality weekly report. 2002;51(RR-7).

Mercer BM, Crouse DT, Goldenberg RL, Miodovnik M, Mapp DC, Meis PJ, et al. The antibiotic treatment of PPROM study: systemic maternal and fetal markers and perinatal outcomes. Am J Obstet Gynecol. 2012;206(2):145-9.

Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel L, Hassan S. The role of inflammation and infection in Preterm Birth. Semin Reprod Med. 2007;25(1):21-39.

Goepfert AR, Goldenberg RL, Andrews WW, Hauth JC, Mercer B, Iams J et al. The NICHD-MFMU The Preterm Prediction Study: association between cervical interleukin 6 concentration and spontaneous preterm birth.Am J Obstet Gynecol. 2001;184(3):483-8.

Le Ray I, Mace G, Sediki M, Lirussi F, Riethmuller D, Lentz N et al. Maternal blood inflammatory markers as a predictor of chorioamnionitis: a prospective multicenter study. Am J Reprod Immunol. 2015;73(1):79-90.

Yoon BH, Romero R, Park JS, Kim CJ, Kim SH, Choi JH, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at age three years. Am J Obstet Gynecol. 2000;182(3):675-81.

Yoon BH, Jun JK, Romero R, Park KH, Gomez R, Choi JH et al. Amniotic fluid inflammatory cytokines (interleukin-6,interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol. 1997;177(1):19-26.

Yoon BH, Romero R, Kim CJ, Jun JK, Gomez R, Choi JH et al. Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol. 1995;172(3):960-70.

Yoon BH, Yang SH, Jun JK, Park KH, Kim CJ, Romero R. Maternal Blood C-Reactive Protein, White Blood Cell Count, and Temperature in Preterm Labor: A Comparison with Amniotic Fluid White Blood Cell Count. Obstet Gynecol. 1996(a);87(2):231-7.

Yoon BH, Jung JK, Park KH, Syn HC, Gomez R, Romero R. Serum C-reactive protein, white bloodcell count and amniotic fluid white blood cell count in women with preterm premature rupture of membranes. Obstet Gynecol. 1996(b);88(6):1034-40.

Weeks JW, Reynolds L, Taylor D, Lewis J, Wan T, Gall SA. Umbilical cord blood interleukin-6levels and neonatal morbidity. Obstet Gynecol. 1997;90:815-8.

Goepfert AR, Andrews WW, Carlo W, Ramsey PS, Cliver SP, Golenberg RL et al. Umbilical cord plasma interleukin-6 concentrations in preterm infants and risk of neonatal morbidity. Am J Obstet Gynecol .2004;191(4):1371-81.

Yoon BH, Romero R, Yang SH, Jun JK, Kim IO, Choi JH, et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol .1996;174(5):1433-40.

Kassal R, Anwar M, Kashlan F, Smulian J, Hiatt M, Hegyi T. Umbilical vein interleukin-6 levels in very low birth weight infants developing intraventricular hemorrhage. Brains and Development 2005; 27(7):483-87.

Yoon BH, Romero R, Park JS, Kim M, Oh SY, Kim CJ, et al. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol 2000;183(5):1124-9.

Yoon BH, Romero R, Park JS, Kim M, Oh SY, Kim CJ, et al. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999;181(4):773-9.

Heep A, Behrendt D, Nitsch P, Fimmers R, Bartmann P, Dembinski J. Increased serum levels ofinterleukin 6 are associated with severe intraventricular haemorrhage in extremely premature infants.Arch Dis Child Fetal Neonatal Ed. 2003;88(6):501-4.

Romero R, Yoon BH, Mazor M, Gomez R, Gonzalez R, Diamond MP, et al. A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and Gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1993;169(4):839–51.

Mercer BM, Crouse DT, Goldenberg RL, Miodovnik M, Mapp DC, Meis PJ, et al. The antibiotic treatment of PPROM study: systemic maternal and fetal markers and perinatal outcomes. Am J Obstet Gynecol 2012; 206(2):145-9.

Mercer B. The NICHD-MFMU antibiotic treatment of PPROM study: evaluation of factors associated with successful outcome. Am J Obstet Gynecol. 1997;176(2):S8

Owen J, Groome LJ, Hauth JC. Randomized trial of prophylactic therapy after preterm amnion rupture.Am J Obstet Gynecol. 1993;169(4):976–81.

Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE 1 randomized trial. Lancet. 2001;357(9261):979-88.

Amon E, Lewis SV, Sibaj BM, Villar MA, Arheart KL. Ampicillin prophylaxis in preterm premature rupture of membranes: a prospective randomized study. Am J Obstet Gynecol. 1988;159(3):539-43.

Greig PC, Murtha AP, Jimmerson CJ, Herbert WP, Roitman-Johnson B, Allen J. Maternal serum interleukin-6 during pregnancy and during term and preterm labor. Obstet Gynecol. 1997;90(3):465-9.

Murtha AP, Greig PC, Jimmerson CE, Herbert WNP. Maternal serum interleukin-6 concentration as a marker for impending preterm delivery. Obstet Gynecol. 1998;91(2):161–4.

Howman RA, Charles AK, Jacques A, Doherty DA, Simmer K, Strunk T, et al. Inflammatory and Haematological Markers in the Maternal, Umbilical Cord and Infant Circulation in Histological Chorioamnionitis. PLos One 2012;7(12):e51836.

Cobo T, Kacerovsky M, Andrys C, Drahosova M, Musilova I, Hornychova H, et al. Umbilical Cord Blood IL-6 as Predictor of Early-Onset Neonatal Sepsis in Women with Preterm Prelabour Rupture of Membranes. PLoS ONE. 2013;8(7):e69341.